ӳ����ý

1990-2001 The Whitehead Institute Center for Genome Research generated data for the Human Genome Project, contributing approximately one-third of the project's draft sequence. 

January 2001 Initial sequencing and analysis of the human genome published in Nature.

November 2003 ӳ����ý of MIT and Harvard is established at 320 Charles Street in Cambridge, Massachusetts, a storied location that served multiple purposes throughout its long history, including as a Budweiser Beer distribution center and a storage facility for concessions served at Fenway Park. 

December 2003 The International HapMap Project paper is published in Nature, with the majority of data produced by what is now the Genomics Platform.

September 2005 ӳ����ý received a 454 GS20 Sequencer, the first “next generation sequencing” instrument to reach the market.

December 2005 NIH launched The Cancer Genome Atlas (TCGA) project, with what is now the Genomics Platform piloting the project.

November 2006 NHGRI named ӳ����ý as one of three large-scale sequencing centers for TCGA.

2007-2009 ӳ����ý scaled up its sequencing capacity, becoming the world's largest sequencing center.

January 2012 Three prior ӳ����ý platforms merged to become the Genomics Platform.

December 2013 The Genomics Platform launched the Clinical Research Sequencing Platform (CRSP) to provide physicians and researchers access to CLIA-regulated whole exome sequencing.

April 2016 ӳ����ý's whole genome analysis moved to the cloud.

April 2018 On the 15th anniversary of the completion of the Human Genome Project, the Genomics Platform completed sequencing of its 100,000th whole human genome.

July 2018 Data generation hit a monthly high record of 700+ terabases, equivalent to completing a human genome every five and a half minutes.

March 2020 The Genomics Platform converted its clinical sequencing facility into a high-throughput COVID diagnostic testing center.

April 2021 The COVID testing facility achieved a peak of 148,000 tests processed in a single day. 

January 2022 The Genomics Platform returned results for its 30 millionth COVID test.

June 2023 COVID testing wound down, having processed more than 37 million COVID tests in service of the public health needs of the Commonwealth of Massachusetts and surrounding areas. 

October 2023 The Clinical Research Sequencing Platform (CRSP) evolved into the . BCL supports large-scale projects for which results need to be generated under a clinical quality system, such as analyses for clinical trials, biobank profiling, and other projects where results may be returned to participants or integrated into health records.

November 2023 Genomics Platform/BCL sequenced their 500,000th human whole genome.

April 2024 Genomics Platform/ӳ����ý Clinical Labs sequenced its 1 millionth human exome (including blended genome exomes), after first launching the product in 2008.

September 2024 The Genomics Platform and BCL left their long-time home at 320 Charles Street for a new facility at 27 Blue Sky Drive in Burlington, Massachusetts.

April 2025 , with the goal of enabling a sustainable model for patient and community engagement coupled with research and clinical data generation and analysis.